Ligand Pharmaceuticals
LGND
#3412
Rank
C$5.53 B
Marketcap
C$277.72
Share price
0.65%
Change (1 day)
73.72%
Change (1 year)

Operating Margin for Ligand Pharmaceuticals (LGND)

Operating Margin as of March 2026 (TTM): 59.29%

According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 59.29%. At the end of 2025 the company had an Operating Margin of 59.29%.

Operating Margin history for Ligand Pharmaceuticals from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202559.29%3835.67%
20241.51%-96.89%
202348.48%164.19%
202218.35%-38.61%
202129.89%3684.35%
20200.79%-99.88%
2019662.31%860.82%
201868.93%69.95%
201740.56%455.27%
20167.30%-85.13%
201549.13%180.53%
201417.51%-6.84%
201318.80%-252.66%
2012-12.31%3.95%
2011-11.85%-81.9%
2010-65.44%158.12%
2009-25.35%-92.9%
2008-357.00%-13.89%
2007-414.58%-78.13%
2006-1,895.80%357.43%
2005-414.45%1957.31%
2004-20.15%-82.69%
2003-116.39%59.98%
2002-72.75%140.04%
2001-30.31%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-41.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.01%-79.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
39.47%-33.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
24.42%-58.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-4.49%-107.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
32.40%-45.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
19.35%-67.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
22.60%-61.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-109.76%-285.12%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.